Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IN-CROSS LDL-C switching study
2006-005513-35Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypercholesterolemia comparing Inegy arm with Crestor arm (2 arms). Primary endpoint: LDL cholesterol lowering. Started Jan 2007; status: completed.
02
Drugs
ezetimiberosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2006-005513-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005513-35.